ArticleNature communications2025

HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model.

Oliver McCallion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.